SHS Gesellschaft für Beteiligungsmanagement mbH

Newsletter Current page: 9

4. February 2021 - Newsletter

Regulatory approval for the highly sensitive, high-speed coronavirus test system by GNA Biosolutions

Coming up with reliable figures for the process of infection with the coronavirus requires tests that are dependable and, above all, quick. With the Octea SARS-CoV-2 system, GNA Biosolutions has developed a molecular, highly sensitive test method that delivers a test result with 96.7 percent accuracy in decentralized laboratories in approximately 40 minutes’ time. Octea […]

Read more
4. February 2021 - Newsletter

SHS invests in innovative specialist for drugs formulated specifically for delayed-release effects

Develco Pharma, a Swiss-German firm, has been developing and producing orally administered, delayed-release drugs with special formulations since 2006. Since 2016, the company has produced these drugs in a state-of-the-art production facility located in Schopfheim, in the Baden region of Germany. The dynamic, medium-sized company is gradually growing its pipeline for new drugs, and there […]

Read more
First Previous
...
78
9
1011
...
Next Last